Overview
Ghanem Daghestani is a Hematologist Oncology specialist and an Oncologist in Mcallen, Texas. Dr. Daghestani is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Daghestani is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1901 S 2nd St, Mcallen, TX 78503
Mcallen Oncology PA
Eugenio Galindo is a Hematologist Oncology specialist and a Hematologist in Mcallen, Texas. Dr. Galindo is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Testicular Yolk Sac Tumor. Dr. Galindo is currently accepting new patients.
Valley Cancer Associates PA
Todd Shenkenberg is a Hematologist Oncology specialist and a Hematologist in Harlingen, Texas. Dr. Shenkenberg is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Adult Immune Thrombocytopenia, Gastrostomy, and Endoscopy.
Mcallen Oncology PA
Paul Holoye is a Hematologist Oncology specialist and a Hematologist in Mcallen, Texas. Dr. Holoye is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Holoye is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Daghestani isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Daghestani isDistinguished. Learn about Familial Colorectal Cancer.
- Paget Disease of the BreastDr. Daghestani isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Breast CancerDr. Daghestani isAdvanced. Learn about Breast Cancer.
- Familial Prostate CancerDr. Daghestani isAdvanced. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Daghestani isAdvanced. Learn about Inflammatory Breast Cancer.
- Intraductal PapillomaDr. Daghestani isAdvanced. Learn about Intraductal Papilloma.
- Lung CancerDr. Daghestani isAdvanced. Learn about Lung Cancer.
- Lynch SyndromeDr. Daghestani isAdvanced. Learn about Lynch Syndrome.
- Experienced
- Acute Eosinophilic PneumoniaDr. Daghestani isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Daghestani isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Daghestani isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Daghestani isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Daghestani isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Daghestani isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.